Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATOM-J: 0.01% atropine eye drops for controlling progression of childhood myopia
jRCTs051180041Completed
- Sponsor
- Japanese Research Center of Refractive Surgery
- Start
- Aug 2015
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in myopia comparing 0.01% atropine ophthalmic solution with Placebo ophthalmic solution (2 arms). Primary endpoint: Change from baseline in objective spherical equivalent at 24 months. Started Aug 2015; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on jRCTs051180041.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180041.